Original Research
Accepted on 25 Jun 2025
Exosomal miR-93-3p Targets EIF4EBP1 to Regulate Macrophage Polarization and Accelerate Wound Healing Post-anal Fistula Surgery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1599633
27,000 Publications
Volume 16 - 2025
Original Research
Accepted on 25 Jun 2025
Therapeutic Efficacy of Rhoifolin in Type 2 Diabetes Mellitus: Effects on Metabolic Parameters, Hepatic Function, and Oxidative Stress: A Dose-Dependent Study
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1595323
Original Research
Accepted on 25 Jun 2025
The active components of Eucommia ulmoides leaves alleviates atherosclerosis induced by high-fat diet and VD3 in rats
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1625200
Systematic Review
Accepted on 25 Jun 2025
Protective effects of curcumin on epileptic rodent models by alleviating oxidative stress and inflammation: a meta-analysis and mechanism exploration
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1602716
Original Research
Accepted on 25 Jun 2025
Population pharmacokinetic analysis of remimazolam after continuous infusion for sedation in critically ill patients
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1526266
Review
Accepted on 25 Jun 2025
Research Progress in Treatment of Rheumatoid Arthritis with Sinomenine and Related Formulations Based on Different Administration Routes
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613679
Original Research
Accepted on 25 Jun 2025
Patterns and Predictors of Self-medication behavior of Weight Loss Medications: A Cross-Sectional Analysis of Social media influence and Role of Pharmacist Intervention
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1606566
Original Research
Accepted on 25 Jun 2025
Bitter Taste Receptor Agonists Induce Vasorelaxation in Porcine Coronary Arteries
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578913
Correction
Accepted on 25 Jun 2025
Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1646562
Original Research
Accepted on 25 Jun 2025
Dihydroartemisinin Targets the miR-497-5p/SOX5 Axis to Suppress Tumor Progression in Non-Small Cell Lung Cancer
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1605531
Editorial
Accepted on 25 Jun 2025
Editorial: Pharmacogenomics for Improving Drug Safety and Efficacy in Cancer
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1649258
Review
Accepted on 25 Jun 2025
Beyond Antibiotics: Probiotics as a Promising Ally Against Helicobacter pylori
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620870
Case Report
Accepted on 25 Jun 2025
Spermatocytic Tumor Associated With Metastases: Report of a Rare Case and Literature Review
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1636142
Original Research
Accepted on 25 Jun 2025
The GPR30 Agonist G-1 Promotes Hair Growth via Wnt/Hedgehog Signaling in Mice
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1570922
Correction
Accepted on 25 Jun 2025
Resveratrol and Angiogenin-2 Combined With PEGDA/TCS Hydrogel for the Targeted Therapy of Hypoxic Bone Defects via Activation of the Autophagy Pathway
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1597755
Original Research
Accepted on 25 Jun 2025
Efficacy and Safety of Telitacicept in Systemic Lupus Erythematosus with Lupus Nephritis and Nephrotic Syndrome: A 12-Month Retrospective Cohort Study
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613790